# Lin, James P MD Inc – FDA Inspection, Feb 28, 2011

Source: https://www.keypedia.com/records/fda_inspections/lin-james-p-md-inc/7405659c-9029-4993-8b8f-92a9170fe72a
Source feed: FDA_Inspections

> FDA inspection 712951 of Lin, James P MD Inc, February 28, 2011. Classification: No Action Indicated (NAI). 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 712951
- Company Name: Lin, James P MD Inc
- Inspection Date: 2011-02-28
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1263504 - 2025-03-12](https://www.keypedia.com/records/fda_inspections/lin-james-p-md-inc/62664eb0-bc6b-4b3c-b6f0-faf954ad59a4)
- FDA Inspection 1182334 - 2022-10-19
- FDA Inspection 1034922 - 2017-10-30
- [FDA Inspection 859037 - 2013-12-24](https://www.keypedia.com/records/fda_inspections/lin-james-p-md-inc/6ea3123a-2c1e-490b-b2da-9b3756927456)
- FDA Inspection 813194 - 2013-01-11

Company: https://www.keypedia.com/companies/lin-james-p-md-inc/c4590b97-dbd4-4dfb-b300-b24667453442

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d